27.04.2017 22:06:09
|
Vertex Pharmaceuticals Inc. Q1 Profit Advances 352%
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) released earnings for its first quarter that increased from last year.
The company said its bottom line rose to $101.41 million, or $0.41 per share. This was up from $22.42 million, or $0.09 per share, in last year's first quarter.
Analysts had expected the company to earn $0.4 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company said revenue for the quarter rose 79.5% to $714.72 million. This was up from $398.08 million last year.
Vertex Pharmaceuticals Inc. earnings at a glance:
-Earnings (Q1): $101.41 Mln. vs. $22.42 Mln. last year. -Earnings Growth (Y-o-Y): 352.3% -EPS (Q1): $0.41 vs. $0.09 last year. -EPS Growth (Y-o-Y): 355.6% -Analysts Estimate: $0.4 -Revenue (Q1): $714.72 Mln vs. $398.08 Mln last year. -Revenue Change (Y-o-Y): 79.5%

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vertex Pharmaceuticals Inc.mehr Nachrichten
Analysen zu Vertex Pharmaceuticals Inc.mehr Analysen
Aktien in diesem Artikel
Vertex Pharmaceuticals Inc. | 461,35 | 2,90% |
|